Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Vanhove

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
British Journal of Clinical Pharmacology|April 26, 2018
Kuypers and Vanhove reply to 'Was 4β-hydroxycholesterol ever going to be a useful marker of CYP3A4 activity?' by Neuhoff and TuckerDirk R J Kuypers, Thomas Vanhove
Transplantation Proceedings|November 1, 2025
Immunosuppression Minimization in Belatacept-Treated Kidney Transplant Recipients Guided by Combined Cell-Free DNA and Blood Gene Expression MonitoringThomas Vanhove, David Wojciechowski, Hannah Gilligan
Transplantation|December 13, 2016
Kidney Fibrosis: Origins and InterventionsThomas Vanhove, Roel Goldschmeding, Dirk Kuypers
British Journal of Clinical Pharmacology|February 8, 2017
Response to: 'Bodyweight-adjustments introduce significant correlations between CYP3A metrics and tacrolimus clearance'Thomas Vanhove, Pieter Annaert, Dirk R J Kuypers
Transplantation Reviews (Orlando, Fla.)|September 26, 2016
Drug-drug interactions between immunosuppressants and antidiabetic drugs in the treatment of post-transplant diabetes mellitusThomas Vanhove, Quinten Remijsen, Dirk Kuypers, et al.
Drug Metabolism Reviews|February 26, 2016
Clinical determinants of calcineurin inhibitor disposition: a mechanistic reviewThomas Vanhove, Pieter Annaert, Dirk R J Kuypers
Informatics for Health & Social Care|February 19, 2016
Intelligent task management platform for health care workersFemke Ongenae, Thomas Vanhove, Femke De Backere, et al.
Journal of Pharmaceutical and Biomedical Analysis|August 15, 2021
Determination of tacrolimus, three mono-demethylated metabolites and a M1 tautomer in human whole blood by liquid chromatography - tandem mass spectrometryHenriette de Loor, Thomas Vanhove, Pieter Annaert, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 14, 2017
A noninferiority trial comparing a heparin-grafted membrane plus citrate-containing dialysate versus regional citrate anticoagulation: results of the CiTED studyBjörn Meijers, Christoph Metalidis, Thomas Vanhove, et al.
British Journal of Clinical Pharmacology|June 13, 2017
Pretransplant 4β-hydroxycholesterol does not predict tacrolimus exposure or dose requirements during the first days after kidney transplantationThomas Vanhove, Mahmoud Hasan, Pieter Annaert, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
British Journal of Clinical Pharmacology|April 26, 2018
Kuypers and Vanhove reply to 'Was 4β-hydroxycholesterol ever going to be a useful marker of CYP3A4 activity?' by Neuhoff and TuckerDirk R J Kuypers, Thomas Vanhove
Transplantation Proceedings|November 1, 2025
Immunosuppression Minimization in Belatacept-Treated Kidney Transplant Recipients Guided by Combined Cell-Free DNA and Blood Gene Expression MonitoringThomas Vanhove, David Wojciechowski, Hannah Gilligan
Transplantation|December 13, 2016
Kidney Fibrosis: Origins and InterventionsThomas Vanhove, Roel Goldschmeding, Dirk Kuypers
British Journal of Clinical Pharmacology|February 8, 2017
Response to: 'Bodyweight-adjustments introduce significant correlations between CYP3A metrics and tacrolimus clearance'Thomas Vanhove, Pieter Annaert, Dirk R J Kuypers
Transplantation Reviews (Orlando, Fla.)|September 26, 2016
Drug-drug interactions between immunosuppressants and antidiabetic drugs in the treatment of post-transplant diabetes mellitusThomas Vanhove, Quinten Remijsen, Dirk Kuypers, et al.
Drug Metabolism Reviews|February 26, 2016
Clinical determinants of calcineurin inhibitor disposition: a mechanistic reviewThomas Vanhove, Pieter Annaert, Dirk R J Kuypers
Informatics for Health & Social Care|February 19, 2016
Intelligent task management platform for health care workersFemke Ongenae, Thomas Vanhove, Femke De Backere, et al.
Journal of Pharmaceutical and Biomedical Analysis|August 15, 2021
Determination of tacrolimus, three mono-demethylated metabolites and a M1 tautomer in human whole blood by liquid chromatography - tandem mass spectrometryHenriette de Loor, Thomas Vanhove, Pieter Annaert, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 14, 2017
A noninferiority trial comparing a heparin-grafted membrane plus citrate-containing dialysate versus regional citrate anticoagulation: results of the CiTED studyBjörn Meijers, Christoph Metalidis, Thomas Vanhove, et al.
British Journal of Clinical Pharmacology|June 13, 2017
Pretransplant 4β-hydroxycholesterol does not predict tacrolimus exposure or dose requirements during the first days after kidney transplantationThomas Vanhove, Mahmoud Hasan, Pieter Annaert, et al.
Pageof 3